Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic

Journal of the American Academy of Dermatology(2020)10.1016/j.jaad.2020.06.1014Source: DataRank Database

The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic is a research paper published in Journal of the American Academy of Dermatology (2020). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: bronzeTopics (42)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Daniel B. Shin ORCID,Marilyn T. Wan ORCID,Kevin Winthrop ORCID,Joel M. Gelfand ORCID,Maha N. Syed ORCID

Live enrichment

PubMed:32622891 PMC:PMC7331500

NIAMS NIH HHS

Grant: P30 AR069589

National Institutes of Health

Grant: 5P30AR069589-03

Penn Resource-based Center to Support and Translate Skin DiseasesResearch

National Institutes of Health

bronzeLicense: Elsevier TDM

publisherhttp://www.jaad.org/article/S0190962220321150/pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7331500

Europe_PMChttps://europepmc.org/articles/PMC7331500

Europe_PMChttps://europepmc.org/articles/PMC7331500?pdf=render

https://doi.org/10.1016/j.jaad.2020.06.1014

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansRespiratory Tract InfectionsPneumonia, ViralCoronavirus InfectionsPsoriasisBiological ProductsAntibodies, MonoclonalOdds RatioRisk AssessmentSignal TransductionInterleukin-23 Subunit p19Clinical Trials, Phase II as TopicClinical Trials, Phase III as TopicPandemicsAntibodies, Monoclonal, HumanizedClinical Decision-MakingBetacoronavirusCOVID-19SARS-CoV-2

Keywords

Biological ProductsSARS-CoV-2Clinical Decision-MakingPneumonia, ViralAntibodies, MonoclonalCOVID-19DermatologyAntibodies, Monoclonal, HumanizedRisk AssessmentBetacoronavirusClinical Trials, Phase II as TopicClinical Trials, Phase III as TopicResearch LetterInterleukin-23 Subunit p19Odds RatioHumansPsoriasisCoronavirus InfectionsPandemicsRespiratory Tract InfectionsSignal Transduction

The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic

FAIR Checklist

Authors (5)

Funding (3 grants)

Open Access

Topics

Annotations (Europe PMC)